Skip to main content
Top
Published in: International Urology and Nephrology 3/2010

01-09-2010 | Nephrology – Letter to the Editor

Bleeding complications associated with percutaneous renal biopsy using Biopince® needle

Authors: Sumanth R. Daram, Venkata Reddivari, Bahar Bastani

Published in: International Urology and Nephrology | Issue 3/2010

Login to get access

Excerpt

Renal biopsy is a valuable tool in the diagnosis of renal diseases; however, bleeding remains a serious complication of the procedure [14]. We have used 18-G BioPince® (Full Core Biopsy Instrument; Medical Device Technologies Inc. Gainesville, FL) needle for performing renal biopsies in the recent years. BioPince technology is built around a tri-axial “Cut and Trap” cannula system, which is designed to cut the specimen and hold it in the cannula. This mechanism supposedly delivers cylindrical, full-length specimens that are complete and largely undamaged, thereby greatly improving the diagnostic value of the sample. This instrument is also claimed to result in less trauma to the patient, and less crush artifact and tissue fragmentation. …
Literature
1.
go back to reference Whittier WL, Korbet SM (2004) Timing of complications in percutaneous renal biopsy. J Am Soc Nephrol 15:142CrossRefPubMed Whittier WL, Korbet SM (2004) Timing of complications in percutaneous renal biopsy. J Am Soc Nephrol 15:142CrossRefPubMed
2.
go back to reference Parrish AE (1992) Complications of percutaneous renal biopsy: a review of 37 years experience. Clin Nephrol 38:135–141PubMed Parrish AE (1992) Complications of percutaneous renal biopsy: a review of 37 years experience. Clin Nephrol 38:135–141PubMed
3.
go back to reference Manno C, Strippoli GFM, Arnesano L et al (2004) Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy. Kidney Int 66:1570–1577CrossRefPubMed Manno C, Strippoli GFM, Arnesano L et al (2004) Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy. Kidney Int 66:1570–1577CrossRefPubMed
4.
go back to reference Shidham GB, Siddiqi N, Beres JA et al (2005) Clinical Risk Factors associated with bleeding after native kidney biopsy. Nephrology 10:305–310CrossRefPubMed Shidham GB, Siddiqi N, Beres JA et al (2005) Clinical Risk Factors associated with bleeding after native kidney biopsy. Nephrology 10:305–310CrossRefPubMed
5.
go back to reference Kjajehdehi P, Junaid SMA, Salinas-Madrigal L et al (1999) Percutaneous renal biopsy in the 1990s: safety, value and implications for early hospital discharge. Am J Kidney Dis 34:92–97CrossRef Kjajehdehi P, Junaid SMA, Salinas-Madrigal L et al (1999) Percutaneous renal biopsy in the 1990s: safety, value and implications for early hospital discharge. Am J Kidney Dis 34:92–97CrossRef
Metadata
Title
Bleeding complications associated with percutaneous renal biopsy using Biopince® needle
Authors
Sumanth R. Daram
Venkata Reddivari
Bahar Bastani
Publication date
01-09-2010
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 3/2010
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-010-9773-0

Other articles of this Issue 3/2010

International Urology and Nephrology 3/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine